Quantessence Capital’s Gevo GEVO Stock Holding History

Quantessence Capital’s Portfolio GEVO Stock Details GEVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-122,614	Closed	-$142K	–	284
2025 Q1	$142K	Buy	+122,614	New	+$205K	0.04%	291

Other funds holding GEVO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $39.1B AUM 28.69% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Quantessence Capital's GEVO Position: Q2 2025 in Review

Quantessence Capital sold out of Gevo (GEVO) in Q2 2025, closing a stake of 122,614 shares — an estimated $142K sold.

Quantessence Capital first reported a position in GEVO in Q1 2025 and held it in 1 quarter. The position peaked at $142K in Q1 2025. 121 funds tracked by Wall St. Rank hold GEVO as of Q2 2025.

Quantessence Capital reported no remaining Gevo position as of Q2 2025 after selling out during the quarter.
Quantessence Capital sold 122,614 Gevo shares in Q2 2025, an estimated $142K.
Quantessence Capital first reported a position in Gevo in Q1 2025 and held it in 1 quarter.
Quantessence Capital's Gevo position peaked at $142K in Q1 2025.
121 funds tracked by Wall St. Rank held Gevo as of Q2 2025.

Based on Quantessence Capital's 13F filing for Q2 2025, filed 14 Aug 2025.